BioRestorative Therapies, Inc. (BRTX) [Rocket]

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13
	S-1/A	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Net income	-11.3	-14.6	-12.5	-9.4	-8.6	-7.9	-5.6	-5.8
Depreciation and amortization	0.1	0.2	0.2	0.3	0.3	0.2	0.1	0.1
Asset impairment charges							0.0
Stock-based compensation	0.7	1.7	2.4	3.6	2.5	2.0	1.4	0.8
Change in working capital [+]	0.6	0.5	0.0	0.8	0.2	2.1	0.5	1.5
Accounts receivable	0.0	0.0	0.0	0.0	0.1	-0.1
Inventories								0.0
Other current assets	-0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accounts payable	0.1	0.1	-0.5	0.2	-0.1	1.4	-0.2	0.5
Accrued expenses	0.5	0.4	0.5	0.6	0.2	1.0		1.0
Deferred revenues						-0.2	0.2
Other						-0.1	0.6
Other operating activities	7.9	5.3	4.8	0.9	0.7	0.6	0.4	0.6
Cash from operations	-2.0	-6.9	-5.1	-3.9	-5.0	-3.1	-3.2	-2.7

Capital expenditures [+]	0.0	0.0	0.0	0.0	-0.2	-0.4	-0.2	0.0
Purchases of property and equipment		0.0	0.0	0.0	-0.2	-0.4	-0.2	0.0
Sales of property and equipment							0.0
Other cash from investing	2.5					-0.1
Cash from investing	2.5	0.0	0.0	0.0	-0.2	-0.5	-0.2	0.0

Issuance of common stock, net	0.0				0.0
Financing costs	-0.5
Other cash from financing	4.5	6.8	4.8	4.3	5.0	3.7	3.3	2.9
Cash from financing	5.0	6.8	4.8	4.3	5.1	3.7	3.3	2.9

Free cash flow	-2.0	-7.0	-5.1	-3.9	-5.2	-3.5	-3.4	-2.7
Per share (diluted)	($4.98)	($0.31)	($0.67)	($0.71)	($1.26)	($1.43)	($2.66)	($0.16)

Cash paid for interest		0.4	0.0	0.0	0.0	0.1	0.1	0.1